These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 17360538)

  • 81. Gene Therapy Restores Balance and Auditory Functions in a Mouse Model of Usher Syndrome.
    Isgrig K; Shteamer JW; Belyantseva IA; Drummond MC; Fitzgerald TS; Vijayakumar S; Jones SM; Griffith AJ; Friedman TB; Cunningham LL; Chien WW
    Mol Ther; 2017 Mar; 25(3):780-791. PubMed ID: 28254438
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A detailed clinical and molecular survey of subjects with nonsyndromic USH2A retinopathy reveals an allelic hierarchy of disease-causing variants.
    Lenassi E; Vincent A; Li Z; Saihan Z; Coffey AJ; Steele-Stallard HB; Moore AT; Steel KP; Luxon LM; Héon E; Bitner-Glindzicz M; Webster AR
    Eur J Hum Genet; 2015 Oct; 23(10):1318-27. PubMed ID: 25649381
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Localization of PDZD7 to the stereocilia ankle-link associates this scaffolding protein with the Usher syndrome protein network.
    Grati M; Shin JB; Weston MD; Green J; Bhat MA; Gillespie PG; Kachar B
    J Neurosci; 2012 Oct; 32(41):14288-93. PubMed ID: 23055499
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Four USH2A founder mutations underlie the majority of Usher syndrome type 2 cases among non-Ashkenazi Jews.
    Auslender N; Bandah D; Rizel L; Behar DM; Shohat M; Banin E; Allon-Shalev S; Sharony R; Sharon D; Ben-Yosef T
    Genet Test; 2008 Jun; 12(2):289-94. PubMed ID: 18452394
    [TBL] [Abstract][Full Text] [Related]  

  • 85. USH2A Gene Editing Using the CRISPR System.
    Fuster-García C; García-García G; González-Romero E; Jaijo T; Sequedo MD; Ayuso C; Vázquez-Manrique RP; Millán JM; Aller E
    Mol Ther Nucleic Acids; 2017 Sep; 8():529-541. PubMed ID: 28918053
    [TBL] [Abstract][Full Text] [Related]  

  • 86. USH2A-retinopathy: From genetics to therapeutics.
    Toualbi L; Toms M; Moosajee M
    Exp Eye Res; 2020 Dec; 201():108330. PubMed ID: 33121974
    [TBL] [Abstract][Full Text] [Related]  

  • 87. In Vivo Assessment of Potential Therapeutic Approaches for USH2A-Associated Diseases.
    Pendse ND; Lamas V; Pawlyk BS; Maeder ML; Chen ZY; Pierce EA; Liu Q
    Adv Exp Med Biol; 2019; 1185():91-96. PubMed ID: 31884594
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Peripheral Anomalies in USH2A Cause Central Auditory Anomalies in a Mouse Model of Usher Syndrome and CAPD.
    Perrino PA; Newbury DF; Fitch RH
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33498833
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Generation of three induced pluripotent stem cell lines from a patient with Usher syndrome caused by biallelic c.949C > A and c.1256G > T mutations in the USH2A gene.
    Zaw K; Wong EYM; Zhang X; Zhang D; Chen SC; Thompson JA; Lamey T; McLaren T; De Roach JN; Wilton SD; Fletcher S; Mitrpant C; Atlas MD; Chen FK; McLenachan S
    Stem Cell Res; 2020 Dec; 50():102129. PubMed ID: 33360097
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity.
    Duncan JL; Liang W; Maguire MG; Audo I; Ayala AR; Birch DG; Carroll J; Cheetham JK; Esposti SD; Durham TA; Erker L; Farsiu S; Ferris FL; Heon E; Hufnagel RB; Iannaccone A; Jaffe GJ; Kay CN; Michaelides M; Pennesi ME; Sahel JA;
    Am J Ophthalmol; 2020 Nov; 219():87-100. PubMed ID: 32446738
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Biomarkers in Usher syndrome: ultra-widefield fundus autofluorescence and optical coherence tomography findings and their correlation with visual acuity and electrophysiology findings.
    Mustafic N; Ristoldo F; Nguyen V; Fraser CL; Invernizzi A; Jamieson RV; Grigg JR
    Doc Ophthalmol; 2020 Dec; 141(3):205-215. PubMed ID: 32240425
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Full-field electroretinography, visual acuity and visual fields in Usher syndrome: a multicentre European study.
    Stingl K; Kurtenbach A; Hahn G; Kernstock C; Hipp S; Zobor D; Kohl S; Bonnet C; Mohand-Saïd S; Audo I; Fakin A; Hawlina M; Testa F; Simonelli F; Petit C; Sahel JA; Zrenner E
    Doc Ophthalmol; 2019 Oct; 139(2):151-160. PubMed ID: 31267413
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Unanticipated prognosis for a patient with type 2 Usher syndrome.
    Vezinaw CM; Fishman GA; Chiang J
    Doc Ophthalmol; 2019 Apr; 138(2):161-166. PubMed ID: 30796641
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Usher syndrome: Hearing loss, retinal degeneration and associated abnormalities.
    Mathur P; Yang J
    Biochim Biophys Acta; 2015 Mar; 1852(3):406-20. PubMed ID: 25481835
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Clinical diagnosis of the Usher syndromes. Usher Syndrome Consortium.
    Smith RJ; Berlin CI; Hejtmancik JF; Keats BJ; Kimberling WJ; Lewis RA; Möller CG; Pelias MZ; Tranebjaerg L
    Am J Med Genet; 1994 Mar; 50(1):32-8. PubMed ID: 8160750
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations.
    Dulla K; Slijkerman R; van Diepen HC; Albert S; Dona M; Beumer W; Turunen JJ; Chan HL; Schulkens IA; Vorthoren L; den Besten C; Buil L; Schmidt I; Miao J; Venselaar H; Zang J; Neuhauss SCF; Peters T; Broekman S; Pennings R; Kremer H; Platenburg G; Adamson P; de Vrieze E; van Wijk E
    Mol Ther; 2021 Aug; 29(8):2441-2455. PubMed ID: 33895329
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa.
    Eudy JD; Weston MD; Yao S; Hoover DM; Rehm HL; Ma-Edmonds M; Yan D; Ahmad I; Cheng JJ; Ayuso C; Cremers C; Davenport S; Moller C; Talmadge CB; Beisel KW; Tamayo M; Morton CC; Swaroop A; Kimberling WJ; Sumegi J
    Science; 1998 Jun; 280(5370):1753-7. PubMed ID: 9624053
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Genetic etiology of non-syndromic hearing loss in Europe.
    Del Castillo I; Morín M; Domínguez-Ruiz M; Moreno-Pelayo MA
    Hum Genet; 2022 Apr; 141(3-4):683-696. PubMed ID: 35044523
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    Zhu T; Chen DF; Wang L; Wu S; Wei X; Li H; Jin ZB; Sui R
    Br J Ophthalmol; 2021 May; 105(5):694-703. PubMed ID: 32675063
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Comprehensive Molecular Screening in Chinese Usher Syndrome Patients.
    Sun T; Xu K; Ren Y; Xie Y; Zhang X; Tian L; Li Y
    Invest Ophthalmol Vis Sci; 2018 Mar; 59(3):1229-1237. PubMed ID: 29625443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.